Psychopharmacology Of The Developmental Disabilities (disorders Of Human Learning, Behavior, And Communication)

__Psychopharmacology of the Developmental Disabilities__ explores the use of psychotropic and antiepileptic medications in developmentally disabled patients. A distinguished group of international experts offers comprehensive coverage of traditional psychotropic as well as novel pharmacological agents, antiepileptic drugs, and diet and vitamin treatments. Issues related to litigation, measurement of blood levels, tardive dyskinesia, and behavioral pharmacology are discussed in detail. __Psychopharmacology of the Developmental Disabilities__ provides an excellent overview of what is known about psychoactive drugs and an awareness of the principal social and medical issues posed by these agents. Front Matter....Pages i-xvi Patterns of Drug Use, Methodological Considerations, Measurement Techniques, and Future Trends....Pages 1-28 Litigation and Use of Psychoactive Drugs in Developmental Disabilities....Pages 29-57 Psychotropic Drug Blood Levels: Measurement and Relation to Behavioral Outcome in Mentally Retarded Persons....Pages 58-81 Neuroleptic Medications for Persons with Developmental Disabilities....Pages 82-100 Antiepileptic Drugs....Pages 101-118 Other Psychotropic Drugs: Stimulants, Antidepressants, the Anxiolytics, and Lithium Carbonate....Pages 119-145 Novel Psychoactive Agents in the Treatment of Developmental Disorders....Pages 146-167 Vitamin, Mineral, and Dietary Treatments....Pages 168-196 Tardive Dyskinesia and Developmental Disabilities....Pages 197-215 Issues in Behavioral Pharmacology Implications for Developmental Disorders....Pages 216-238 Conclusions....Pages 239-245 Back Matter....Pages 247-277